Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROSPECTIVE RANDOMIZED CONTROLLED TRIAL EVALUATING THE EFFICACY OF INTRAOPERATIVE ARISTA™ AH POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING ROBOTIC ASSISTED RADICAL PROSTATECTOMY FOR THE TREATMENT OF PROSTATE CANCER

NCT06822036 is registered in ClinicalTrials.gov with St. Antonius Hospital Gronau as lead sponsor.

NCT NCT06822036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06822036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROSPECTIVE RANDOMIZED CONTROLLED TRIAL EVALUATING THE EFFICACY OF INTRAOPERATIVE ARISTA™ AH POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING ROBOTIC ASSISTED RADICAL PROSTATECTOMY FOR THE TREATMENT OF PROSTATE CANCER
Lead sponsor
St. Antonius Hospital Gronau
Phase
Not applicable
Overall status
Recruiting
Start date
January 16, 2025
Completion date
January 30, 2027
Enrollment
362 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

blood loss, postoperative, erectile function, prostate cancer (adenocarcinoma)